Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients
Status:
Unknown status
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
Chronic obstructive pulmonary disease is characterized as inflammatory airway with not fully
reversible airflow limitation.Combination treatment with inhaled corticosteroid (ICS) and
long-acting β2 agonists (LABA)attains an improved control of symptoms and lung function, that
are superior to those associated with either drug alone. However, the treatment efficacy
between high and medium dose of inhaled corticosteroid in combination of LABA is still
unknown. The aim of the current study is to investigate the treatment efficacy with high and
medium dose of fluticasone in combination with salmeterol in COPD patients.
Phase:
Phase 4
Details
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Collaborators:
Far Eastern Memorial Hospital National Taiwan University Hospital
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate Xhance